UBS analyst Kevin Caliendo lowered the firm’s price target on Henry Schein (HSIC) to $70 from $75 and keeps a Neutral rating on the shares. Henry Schein reported an EPS miss, but reiterated its guidance, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC:
- Henry Schein price target lowered to $78 from $86 at Barrington
- Cautious Hold on Henry Schein Amid EPS Shortfall and Uncertain Strategic Partnerships
- Henry Schein backs FY25 adjusted EPS $4.80-$4.94, consensus $4.85
- Henry Schein reports Q2 adjusted EPS $1.10, consensus $1.19
- Is HSIC a Buy, Before Earnings?